Clinical Trials Browser

Phase 1 × Advanced Solid Tumors × sapanisertib × Clear all

NCT02197572 2023-01-23

Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid Tumors

Phase 1 Completed

44 enrolled 25 charts

Other solid neoplasm

Advanced Solid Tumors